QLINEA.ST

Healthcare Medical Devices

Q-linea AB (publ)

SEK 16.65

-0.40 -2.35% today

Price History

Not enough data

Key Stats

Market Cap

315.50M

Avg Volume

7,204

EPS

-SEK 13.20

52W High

SEK 38.43

52W Low

SEK 14.55

Div. Yield

0.0%

Valuation

Forward P/E

-55.50

P/B Ratio

1.15

P/S Ratio

21.84

EV/EBITDA

-1.07

EV/Revenue

10.24

Margins

Gross Margin 50.0%

Operating Margin (820.2%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

209.3%

Return on Equity

(75.5%)

Return on Assets

(37.0%)

Liquidity & Leverage

Current Ratio

117.99

Quick Ratio

85.48

Debt / Equity

0.04

Total Cash

186.77M

Total Debt

11.68M

About

Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland. It offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, including a sample preparation cartridge and an AST disc, used with the Frozen insert. The company also develops Podler, a portable blood culture technology. It serves physicians, hospitals, laboratories, healthcare payers, and the medical profession. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.

qlinea.com